Maze Therapeutics, Inc. (MAZE) SEC Filings — 2025
11 SEC filings for Maze Therapeutics, Inc. (MAZE) in 2025.
Filings
- MAZE Swings to $96.5M Loss Amid Zero License Revenue, R&D Spikes — 10-Q · Nov 6, 2025
- Maze Therapeutics S-1 Signals Resale of $150M Private Placement Shares — S-1 · Oct 17, 2025
- Maze Therapeutics Announces Board and Executive Changes — 8-K · Oct 6, 2025
- Maze Therapeutics Files 8-K: Material Agreement, Equity Sales — 8-K · Sep 11, 2025
- Maze Therapeutics Announces Board and Compensation Changes — 8-K · Sep 2, 2025
- Maze Therapeutics Swings to Loss Amid IPO, R&D Spend — 10-Q · Aug 12, 2025
- Maze Therapeutics Files Q1 2025 10-Q — 10-Q · May 14, 2025
- Maze Therapeutics, Inc. 10-K Filing — 10-K · Mar 31, 2025
- Maze Therapeutics Files IPO Amendment — S-1/A · Jan 30, 2025
- Maze Therapeutics Files S-1/A for IPO — S-1/A · Jan 27, 2025
- Maze Therapeutics Files S-1 for Public Offering — S-1 · Jan 7, 2025